Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 64
Age Group: 18 Years to 85 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: EORTC-1205
Study First Received: April 21, 2015
Last Updated: September 19, 2016
Estimated Primary Completion Date: September 2019
Primary Outcome Measures:
Rate of success to complete the full treatment|Loco-regional failure free survival|Overall survival|Treatment side-effects
Sponsors and Collaborators:
European Organisation for Research and Treatment of Cancer – EORTC
Website Link: https://ClinicalTrials.gov/show/NCT02436733
